Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create…
Investor Insight With a disciplined exploration strategy and a high-grade discovery focus, FinEx Metals is poised to become one of the most…
